Literature DB >> 10551866

Expression of the casein kinase 2 subunits in Chinese hamster ovary and 3T3 L1 cells provides information on the role of the enzyme in cell proliferation and the cell cycle.

D Li1, G Dobrowolska, L D Aicher, M Chen, J H Wright, P Drueckes, E L Dunphy, E S Munar, E G Krebs.   

Abstract

In order to investigate the in vivo functions of protein kinase CK2 (CK2), the expression of Myc-tagged versions of the subunits, Myc-CK2alpha and Myc-CK2beta, was carried out in Chinese hamster ovary cells (CHO cells) and in 3T3 L1 fibroblasts. Cell proliferation in these cells was examined. CHO cells that transiently overexpressed the Myc-CK2beta subunit exhibited a severe growth defect, as shown by a much lower value of [(3)H]thymidine incorporation than the vector controls, and a rounded shrunken morphology. In contrast, cells overexpressing Myc-tagged CK2alpha showed a slightly but consistently higher value of [(3)H]thymidine incorporation than the controls. The defect in cell growth and changes in morphology caused by Myc-CK2beta overexpression were partially rescued by coexpression of Myc-tagged CK2alpha. In parallel to the studies in CHO cells, the stable transfection of Myc-CK2alpha and Myc-CK2beta subunits was achieved in 3T3 L1 fibroblast cells. Similarly, the ectopic expression of Myc-CK2beta, but not Myc-CK2alpha, caused a growth defect. By measuring [(3)H]thymidine incorporation, it was found that expression of Myc-CK2beta prolonged the G(1) phase and inhibited up-regulation of cyclin D1 expression during G(1). In addition, a lower mitotic index and lower mitotic cyclin-dependent kinase activities were detected in Myc-CK2beta-expressing cells. Detailed analysis of stable cells that were synchronously released into the cell cycle revealed that the expression of Myc-CK2beta inhibited cells entering into mitosis and prevented the activation of mitotic cyclin-dependent kinases. Taken together, results from both transient and stable expression of CK2 subunits strongly suggest that CK2 may be involved in the control of cell growth and progression of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551866     DOI: 10.1074/jbc.274.46.32988

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

Authors:  David W Litchfield
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

2.  FW2.2 and cell cycle control in developing tomato fruit: a possible example of gene co-option in the evolution of a novel organ.

Authors:  Bin Cong; Steven D Tanksley
Journal:  Plant Mol Biol       Date:  2006-08-29       Impact factor: 4.076

3.  CK2 phosphorylation of eukaryotic translation initiation factor 5 potentiates cell cycle progression.

Authors:  Miwako Kato Homma; Ikuo Wada; Toshiyuki Suzuki; Junko Yamaki; Edwin G Krebs; Yoshimi Homma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-14       Impact factor: 11.205

4.  Autocatalytic tyrosine-phosphorylation of protein kinase CK2 alpha and alpha' subunits: implication of Tyr182.

Authors:  A Donella-Deana; L Cesaro; S Sarno; A M Brunati; M Ruzzene; L A Pinna
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

5.  A simple hanging drop cell culture protocol for generation of 3D spheroids.

Authors:  Ramsey Foty
Journal:  J Vis Exp       Date:  2011-05-06       Impact factor: 1.355

6.  Tyrosine phosphorylation of protein kinase CK2 by Src-related tyrosine kinases correlates with increased catalytic activity.

Authors:  Arianna Donella-Deana; Luca Cesaro; Stefania Sarno; Maria Ruzzene; Anna Maria Brunati; Oriano Marin; Greg Vilk; Amanda Doherty-Kirby; Gilles Lajoie; David W Litchfield; Lorenzo A Pinna
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

7.  Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia.

Authors:  L Quotti Tubi; S Canovas Nunes; A Brancalion; E Doriguzzi Breatta; S Manni; E Mandato; F Zaffino; P Macaccaro; M Carrino; K Gianesin; L Trentin; G Binotto; R Zambello; G Semenzato; C Gurrieri; F Piazza
Journal:  Leukemia       Date:  2016-08-01       Impact factor: 11.528

8.  Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole.

Authors:  R Battistutta; E De Moliner; S Sarno; G Zanotti; L A Pinna
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

9.  Structural and functional insights into the regulation mechanism of CK2 by IP6 and the intrinsically disordered protein Nopp140.

Authors:  Won-Kyu Lee; Sang Hyeon Son; Bong-Suk Jin; Jung-Hyun Na; Soo-Youl Kim; Kook-Han Kim; Eunice Eunkyeong Kim; Yeon Gyu Yu; Hyung Ho Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

10.  Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth.

Authors:  Dan Zhu; Jennifer Hensel; Robert Hilgraf; Mahan Abbasian; Owen Pornillos; Gordafaried Deyanat-Yazdi; Xuequn Helen Hua; Sarah Cox
Journal:  Mol Cell Biochem       Date:  2009-07-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.